Search
Filter Results
Displaying 71–80 of 831 for “retinal diseases”
-
Apr 30, 2024
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmintosa.
-
Jan 23, 2018
Ophthotech Launching Human Study of Emerging Therapy for Stargardt Disease
Ophthotech, a biopharmaceutical company developing therapies for eye diseases, has enrolled the first patient in its Phase 2b clinical trial of Zimura® for people with Stargardt disease caused by mutations in the gene ABCA4.
-
Sep 8, 2014
Fascinating Facts About Retinal Cells
The retina is like a multi-layer cake, with each layer comprised of different types of cells, all playing important roles in retinal health and vision.
-
Jun 15, 2018
The primary goal of the landmark study, funded by the Foundation, is to provide companies and researchers with disease-progression data and potential clinical trial endpoints to drive therapy development
-
Feb 13, 2023
The Foundation Makes an Impact on Retinal Research
The Foundation Fighting Blindness’ long-term impact on moving the inherited retinal disease field forward towards treatments and cures.
-
Apr 30, 2024
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease
-
Mar 22, 2017
Dr. Eliot Berson, Pioneer in Vitamin A Therapy for Retinitis Pigmentosa, Passes Away
Dr. Berson dedicated himself to clinical care and vision-saving research for people with inherited retinal diseases for five decades.
-
Jan 6, 2023
The Retinal Degeneration Fund invests in a $78M Series B for Perceive Biotherapeutics
The investment supports the clinical development of two novel programs, both with the aim of being protective against vision loss.
-
Mar 28, 2012
Vision Testing and Retinal Imaging in Clinical Trials: What Patients Can Expect
Because measuring changes is not always easy, people in clinical trials often undergo a number of different tests over one or several years. It can be challenging for the patient, but is necessary to determine if a treatment is working.
-
Jul 25, 2022
The emerging therapy is designed to restore vision for people with advanced retinal degenerative diseases